Email
Print
- Remicade Biosimilar Market, By Type: Recombinant Non-Glycosylated Protein, Recombinant Glycosylated Protein, and Peptides
- Remicade Biosimilar Market, By Technology: Monoclonal Antibodies (MAb) Technology, Recombinant DNA Technology (rDNA), Nuclear Magnetic Resonance (NMR) Technology, Chromatography, Electrophoresis, Mass Spectrometry, Western Blotting, and Bioassay
- Remicade Biosimilar Market, By Service: Contract Research and Manufacturing Services (CRAMS), and Clinical Trials
- The report has focused study on remicade biosimilar market by basis of application such as: Blood Disorders, Oncology Diseases, Chronic and Autoimmune Diseases, Growth Hormone Deficiencies, and Others
- This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
- Teva Pharmaceutical Industries Ltd.
- Synthon Pharmaceuticals, Inc.
- LG Life Sciences
- Novartis (Sandoz)
- Celltrion
List of Tables:
Table 1: Remicade Biosimilar Market Overview 2023-2030
Table 2: Remicade Biosimilar Market Leader Analysis 2023-2030 (US$)
Table 3: Remicade Biosimilar Market Product Analysis 2023-2030 (US$)
Table 4: Remicade Biosimilar Market End User Analysis 2023-2030 (US$)
Table 5: Remicade Biosimilar Market Patent Analysis 2013-2023* (US$)
Table 6: Remicade Biosimilar Market Financial Analysis 2023-2030 (US$)
Table 7: Remicade Biosimilar Market Driver Analysis 2023-2030 (US$)
Table 8: Remicade Biosimilar Market Challenges Analysis 2023-2030 (US$)
Table 9: Remicade Biosimilar Market Constraint Analysis 2023-2030 (US$)
Table 10: Remicade Biosimilar Market Supplier Bargaining Power Analysis 2023-2030 (US$)
Table 11: Remicade Biosimilar Market Buyer Bargaining Power Analysis 2023-2030 (US$)
Table 12: Remicade Biosimilar Market Threat of Substitutes Analysis 2023-2030 (US$)
Table 13: Remicade Biosimilar Market Threat of New Entrants Analysis 2023-2030 (US$)
Table 14: Remicade Biosimilar Market Degree of Competition Analysis 2023-2030 (US$)
Table 15: Remicade Biosimilar Market Value Chain Analysis 2023-2030 (US$)
Table 16: Remicade Biosimilar Market Pricing Analysis 2023-2030 (US$)
Table 17: Remicade Biosimilar Market Opportunities Analysis 2023-2030 (US$)
Table 18: Remicade Biosimilar Market Product Life Cycle Analysis 2023-2030 (US$)
Table 19: Remicade Biosimilar Market Supplier Analysis 2023-2030 (US$)
Table 20: Remicade Biosimilar Market Distributor Analysis 2023-2030 (US$)
Table 21: Remicade Biosimilar Market Trend Analysis 2023-2030 (US$)
Table 22: Remicade Biosimilar Market Size 2023 (US$)
Table 23: Remicade Biosimilar Market Forecast Analysis 2023-2030 (US$)
Table 24: Remicade Biosimilar Market Sales Forecast Analysis 2023-2030 (Units)
Table 25: Remicade Biosimilar Market, Revenue & Volume, By Type, 2023-2030 ($)
Table 26: Remicade Biosimilar Market By Type, Revenue & Volume, By Recombinant Non-Glycosylated Protein, 2023-2030 ($)
Table 27: Remicade Biosimilar Market By Type, Revenue & Volume, By Recombinant Glycosylated Protein, 2023-2030 ($)
Table 28: Remicade Biosimilar Market By Type, Revenue & Volume, By Peptides, 2023-2030 ($)
Table 29: Remicade Biosimilar Market, Revenue & Volume, By Service, 2023-2030 ($)
Table 30: Remicade Biosimilar Market By Service, Revenue & Volume, By Contract Research and Manufacturing Services (CRAMS), 2023-2030 ($)
Table 31: Remicade Biosimilar Market By Service, Revenue & Volume, By Clinical Trials, 2023-2030 ($)
Table 32: Remicade Biosimilar Market, Revenue & Volume, By Technology, 2023-2030 ($)
Table 33: Remicade Biosimilar Market By Technology, Revenue & Volume, By Monoclonal Antibodies (MAb) Technology, 2023-2030 ($)
Table 34: Remicade Biosimilar Market By Technology, Revenue & Volume, By Recombinant DNA Technology (rDNA Technology), 2023-2030 ($)
Table 35: Remicade Biosimilar Market By Technology, Revenue & Volume, By Nuclear magnetic resonance (NMR) Technology, 2023-2030 ($)
Table 36: Remicade Biosimilar Market By Technology, Revenue & Volume, By Chromatography, 2023-2030 ($)
Table 37: Remicade Biosimilar Market By Technology, Revenue & Volume, By Electrophoresis, 2023-2030 ($)
Table 38: Remicade Biosimilar Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 39: Remicade Biosimilar Market By Application, Revenue & Volume, By Blood Disorders, 2023-2030 ($)
Table 40: Remicade Biosimilar Market By Application, Revenue & Volume, By Oncology Diseases, 2023-2030 ($)
Table 41: Remicade Biosimilar Market By Application, Revenue & Volume, By Chronic and Autoimmune Diseases, 2023-2030 ($)
Table 42: Remicade Biosimilar Market By Application, Revenue & Volume, By Growth Hormone Deficiencies, 2023-2030 ($)
Table 43: North America Remicade Biosimilar Market, Revenue & Volume, By Type, 2023-2030 ($)
Table 44: North America Remicade Biosimilar Market, Revenue & Volume, By Service, 2023-2030 ($)
Table 45: North America Remicade Biosimilar Market, Revenue & Volume, By Technology, 2023-2030 ($)
Table 46: North America Remicade Biosimilar Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 47: South america Remicade Biosimilar Market, Revenue & Volume, By Type, 2023-2030 ($)
Table 48: South america Remicade Biosimilar Market, Revenue & Volume, By Service, 2023-2030 ($)
Table 49: South america Remicade Biosimilar Market, Revenue & Volume, By Technology, 2023-2030 ($)
Table 50: South america Remicade Biosimilar Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 51: Europe Remicade Biosimilar Market, Revenue & Volume, By Type, 2023-2030 ($)
Table 52: Europe Remicade Biosimilar Market, Revenue & Volume, By Service, 2023-2030 ($)
Table 53: Europe Remicade Biosimilar Market, Revenue & Volume, By Technology, 2023-2030 ($)
Table 54: Europe Remicade Biosimilar Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 55: APAC Remicade Biosimilar Market, Revenue & Volume, By Type, 2023-2030 ($)
Table 56: APAC Remicade Biosimilar Market, Revenue & Volume, By Service, 2023-2030 ($)
Table 57: APAC Remicade Biosimilar Market, Revenue & Volume, By Technology, 2023-2030 ($)
Table 58: APAC Remicade Biosimilar Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 59: Middle East & Africa Remicade Biosimilar Market, Revenue & Volume, By Type, 2023-2030 ($)
Table 60: Middle East & Africa Remicade Biosimilar Market, Revenue & Volume, By Service, 2023-2030 ($)
Table 61: Middle East & Africa Remicade Biosimilar Market, Revenue & Volume, By Technology, 2023-2030 ($)
Table 62: Middle East & Africa Remicade Biosimilar Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 63: Russia Remicade Biosimilar Market, Revenue & Volume, By Type, 2023-2030 ($)
Table 64: Russia Remicade Biosimilar Market, Revenue & Volume, By Service, 2023-2030 ($)
Table 65: Russia Remicade Biosimilar Market, Revenue & Volume, By Technology, 2023-2030 ($)
Table 66: Russia Remicade Biosimilar Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 67: Israel Remicade Biosimilar Market, Revenue & Volume, By Type, 2023-2030 ($)
Table 68: Israel Remicade Biosimilar Market, Revenue & Volume, By Service, 2023-2030 ($)
Table 69: Israel Remicade Biosimilar Market, Revenue & Volume, By Technology, 2023-2030 ($)
Table 70: Israel Remicade Biosimilar Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 71: Top Companies 2023 (US$)Remicade Biosimilar Market, Revenue & Volume
Table 72: Product Launch 2023-2030Remicade Biosimilar Market, Revenue & Volume
Table 73: Mergers & Acquistions 2023-2030Remicade Biosimilar Market, Revenue & Volume
List of Figures:
Figure 1: Overview of Remicade Biosimilar Market 2023-2030
Figure 2: Market Share Analysis for Remicade Biosimilar Market 2023 (US$)
Figure 3: Product Comparison in Remicade Biosimilar Market 2023-2030 (US$)
Figure 4: End User Profile for Remicade Biosimilar Market 2023-2030 (US$)
Figure 5: Patent Application and Grant in Remicade Biosimilar Market 2013-2023* (US$)
Figure 6: Top 5 Companies Financial Analysis in Remicade Biosimilar Market 2023-2030 (US$)
Figure 7: Market Entry Strategy in Remicade Biosimilar Market 2023-2030
Figure 8: Ecosystem Analysis in Remicade Biosimilar Market 2023
Figure 9: Average Selling Price in Remicade Biosimilar Market 2023-2030
Figure 10: Top Opportunites in Remicade Biosimilar Market 2023-2030
Figure 11: Market Life Cycle Analysis in Remicade Biosimilar Market
Figure 12: GlobalBy TypeRemicade Biosimilar Market Revenue, 2023-2030 ($)
Figure 13: GlobalBy ServiceRemicade Biosimilar Market Revenue, 2023-2030 ($)
Figure 14: GlobalBy TechnologyRemicade Biosimilar Market Revenue, 2023-2030 ($)
Figure 15: GlobalBy ApplicationRemicade Biosimilar Market Revenue, 2023-2030 ($)
Figure 16: Global Remicade Biosimilar Market - By Geography
Figure 17: Global Remicade Biosimilar Market Value & Volume, By Geography, 2023-2030 ($)
Figure 18: Global Remicade Biosimilar Market CAGR, By Geography, 2023-2030 (%)
Figure 19: North America Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 20: US Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 21: US GDP and Population, 2023-2030 ($)
Figure 22: US GDP – Composition of 2023, By Sector of Origin
Figure 23: US Export and Import Value & Volume, 2023-2030 ($)
Figure 24: Canada Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 25: Canada GDP and Population, 2023-2030 ($)
Figure 26: Canada GDP – Composition of 2023, By Sector of Origin
Figure 27: Canada Export and Import Value & Volume, 2023-2030 ($)
Figure 28: Mexico Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 29: Mexico GDP and Population, 2023-2030 ($)
Figure 30: Mexico GDP – Composition of 2023, By Sector of Origin
Figure 31: Mexico Export and Import Value & Volume, 2023-2030 ($)
Figure 32: South America Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 33: Brazil Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 34: Brazil GDP and Population, 2023-2030 ($)
Figure 35: Brazil GDP – Composition of 2023, By Sector of Origin
Figure 36: Brazil Export and Import Value & Volume, 2023-2030 ($)
Figure 37: Venezuela Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 38: Venezuela GDP and Population, 2023-2030 ($)
Figure 39: Venezuela GDP – Composition of 2023, By Sector of Origin
Figure 40: Venezuela Export and Import Value & Volume, 2023-2030 ($)
Figure 41: Argentina Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 42: Argentina GDP and Population, 2023-2030 ($)
Figure 43: Argentina GDP – Composition of 2023, By Sector of Origin
Figure 44: Argentina Export and Import Value & Volume, 2023-2030 ($)
Figure 45: Ecuador Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 46: Ecuador GDP and Population, 2023-2030 ($)
Figure 47: Ecuador GDP – Composition of 2023, By Sector of Origin
Figure 48: Ecuador Export and Import Value & Volume, 2023-2030 ($)
Figure 49: Peru Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 50: Peru GDP and Population, 2023-2030 ($)
Figure 51: Peru GDP – Composition of 2023, By Sector of Origin
Figure 52: Peru Export and Import Value & Volume, 2023-2030 ($)
Figure 53: Colombia Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 54: Colombia GDP and Population, 2023-2030 ($)
Figure 55: Colombia GDP – Composition of 2023, By Sector of Origin
Figure 56: Colombia Export and Import Value & Volume, 2023-2030 ($)
Figure 57: Costa Rica Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 58: Costa Rica GDP and Population, 2023-2030 ($)
Figure 59: Costa Rica GDP – Composition of 2023, By Sector of Origin
Figure 60: Costa Rica Export and Import Value & Volume, 2023-2030 ($)
Figure 61: Europe Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 62: U.K Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 63: U.K GDP and Population, 2023-2030 ($)
Figure 64: U.K GDP – Composition of 2023, By Sector of Origin
Figure 65: U.K Export and Import Value & Volume, 2023-2030 ($)
Figure 66: Germany Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 67: Germany GDP and Population, 2023-2030 ($)
Figure 68: Germany GDP – Composition of 2023, By Sector of Origin
Figure 69: Germany Export and Import Value & Volume, 2023-2030 ($)
Figure 70: Italy Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 71: Italy GDP and Population, 2023-2030 ($)
Figure 72: Italy GDP – Composition of 2023, By Sector of Origin
Figure 73: Italy Export and Import Value & Volume, 2023-2030 ($)
Figure 74: France Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 75: France GDP and Population, 2023-2030 ($)
Figure 76: France GDP – Composition of 2023, By Sector of Origin
Figure 77: France Export and Import Value & Volume, 2023-2030 ($)
Figure 78: Netherlands Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 79: Netherlands GDP and Population, 2023-2030 ($)
Figure 80: Netherlands GDP – Composition of 2023, By Sector of Origin
Figure 81: Netherlands Export and Import Value & Volume, 2023-2030 ($)
Figure 82: Belgium Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 83: Belgium GDP and Population, 2023-2030 ($)
Figure 84: Belgium GDP – Composition of 2023, By Sector of Origin
Figure 85: Belgium Export and Import Value & Volume, 2023-2030 ($)
Figure 86: Spain Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 87: Spain GDP and Population, 2023-2030 ($)
Figure 88: Spain GDP – Composition of 2023, By Sector of Origin
Figure 89: Spain Export and Import Value & Volume, 2023-2030 ($)
Figure 90: Denmark Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 91: Denmark GDP and Population, 2023-2030 ($)
Figure 92: Denmark GDP – Composition of 2023, By Sector of Origin
Figure 93: Denmark Export and Import Value & Volume, 2023-2030 ($)
Figure 94: APAC Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 95: China Remicade Biosimilar Market Value & Volume, 2023-2030
Figure 96: China GDP and Population, 2023-2030 ($)
Figure 97: China GDP – Composition of 2023, By Sector of Origin
Figure 98: China Export and Import Value & Volume, 2023-2030 ($)Remicade Biosimilar Market China Export and Import Value & Volume, 2023-2030 ($)
Figure 99: Australia Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 100: Australia GDP and Population, 2023-2030 ($)
Figure 101: Australia GDP – Composition of 2023, By Sector of Origin
Figure 102: Australia Export and Import Value & Volume, 2023-2030 ($)
Figure 103: South Korea Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 104: South Korea GDP and Population, 2023-2030 ($)
Figure 105: South Korea GDP – Composition of 2023, By Sector of Origin
Figure 106: South Korea Export and Import Value & Volume, 2023-2030 ($)
Figure 107: India Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 108: India GDP and Population, 2023-2030 ($)
Figure 109: India GDP – Composition of 2023, By Sector of Origin
Figure 110: India Export and Import Value & Volume, 2023-2030 ($)
Figure 111: Taiwan Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 112: Taiwan GDP and Population, 2023-2030 ($)
Figure 113: Taiwan GDP – Composition of 2023, By Sector of Origin
Figure 114: Taiwan Export and Import Value & Volume, 2023-2030 ($)
Figure 115: Malaysia Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 116: Malaysia GDP and Population, 2023-2030 ($)
Figure 117: Malaysia GDP – Composition of 2023, By Sector of Origin
Figure 118: Malaysia Export and Import Value & Volume, 2023-2030 ($)
Figure 119: Hong Kong Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 120: Hong Kong GDP and Population, 2023-2030 ($)
Figure 121: Hong Kong GDP – Composition of 2023, By Sector of Origin
Figure 122: Hong Kong Export and Import Value & Volume, 2023-2030 ($)
Figure 123: Middle East & Africa Remicade Biosimilar Market Middle East & Africa 3D Printing Market Value & Volume, 2023-2030 ($)
Figure 124: Russia Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 125: Russia GDP and Population, 2023-2030 ($)
Figure 126: Russia GDP – Composition of 2023, By Sector of Origin
Figure 127: Russia Export and Import Value & Volume, 2023-2030 ($)
Figure 128: Israel Remicade Biosimilar Market Value & Volume, 2023-2030 ($)
Figure 129: Israel GDP and Population, 2023-2030 ($)
Figure 130: Israel GDP – Composition of 2023, By Sector of Origin
Figure 131: Israel Export and Import Value & Volume, 2023-2030 ($)
Figure 132: Entropy Share, By Strategies, 2023-2030* (%)Remicade Biosimilar Market
Figure 133: Developments, 2023-2030*Remicade Biosimilar Market
Figure 134: Company 1 Remicade Biosimilar Market Net Revenue, By Years, 2023-2030* ($)
Figure 135: Company 1 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2023 (%)
Figure 136: Company 1 Remicade Biosimilar Market Net Sales Share, By Geography, 2023 (%)
Figure 137: Company 2 Remicade Biosimilar Market Net Revenue, By Years, 2023-2030* ($)
Figure 138: Company 2 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2023 (%)
Figure 139: Company 2 Remicade Biosimilar Market Net Sales Share, By Geography, 2023 (%)
Figure 140: Company 3 Remicade Biosimilar Market Net Revenue, By Years, 2023-2030* ($)
Figure 141: Company 3 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2023 (%)
Figure 142: Company 3 Remicade Biosimilar Market Net Sales Share, By Geography, 2023 (%)
Figure 143: Company 4 Remicade Biosimilar Market Net Revenue, By Years, 2023-2030* ($)
Figure 144: Company 4 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2023 (%)
Figure 145: Company 4 Remicade Biosimilar Market Net Sales Share, By Geography, 2023 (%)
Figure 146: Company 5 Remicade Biosimilar Market Net Revenue, By Years, 2023-2030* ($)
Figure 147: Company 5 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2023 (%)
Figure 148: Company 5 Remicade Biosimilar Market Net Sales Share, By Geography, 2023 (%)
Figure 149: Company 6 Remicade Biosimilar Market Net Revenue, By Years, 2023-2030* ($)
Figure 150: Company 6 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2023 (%)
Figure 151: Company 6 Remicade Biosimilar Market Net Sales Share, By Geography, 2023 (%)
Figure 152: Company 7 Remicade Biosimilar Market Net Revenue, By Years, 2023-2030* ($)
Figure 153: Company 7 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2023 (%)
Figure 154: Company 7 Remicade Biosimilar Market Net Sales Share, By Geography, 2023 (%)
Figure 155: Company 8 Remicade Biosimilar Market Net Revenue, By Years, 2023-2030* ($)
Figure 156: Company 8 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2023 (%)
Figure 157: Company 8 Remicade Biosimilar Market Net Sales Share, By Geography, 2023 (%)
Figure 158: Company 9 Remicade Biosimilar Market Net Revenue, By Years, 2023-2030* ($)
Figure 159: Company 9 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2023 (%)
Figure 160: Company 9 Remicade Biosimilar Market Net Sales Share, By Geography, 2023 (%)
Figure 161: Company 10 Remicade Biosimilar Market Net Revenue, By Years, 2023-2030* ($)
Figure 162: Company 10 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2023 (%)
Figure 163: Company 10 Remicade Biosimilar Market Net Sales Share, By Geography, 2023 (%)
Figure 164: Company 11 Remicade Biosimilar Market Net Revenue, By Years, 2023-2030* ($)
Figure 165: Company 11 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2023 (%)
Figure 166: Company 11 Remicade Biosimilar Market Net Sales Share, By Geography, 2023 (%)
Figure 167: Company 12 Remicade Biosimilar Market Net Revenue, By Years, 2023-2030* ($)
Figure 168: Company 12 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2023 (%)
Figure 169: Company 12 Remicade Biosimilar Market Net Sales Share, By Geography, 2023 (%)
Figure 170: Company 13 Remicade Biosimilar Market Net Revenue, By Years, 2023-2030* ($)
Figure 171: Company 13 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2023 (%)
Figure 172: Company 13 Remicade Biosimilar Market Net Sales Share, By Geography, 2023 (%)
Figure 173: Company 14 Remicade Biosimilar Market Net Revenue, By Years, 2023-2030* ($)
Figure 174: Company 14 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2023 (%)
Figure 175: Company 14 Remicade Biosimilar Market Net Sales Share, By Geography, 2023 (%)
Figure 176: Company 15 Remicade Biosimilar Market Net Revenue, By Years, 2023-2030* ($)
Figure 177: Company 15 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2023 (%)
Figure 178: Company 15 Remicade Biosimilar Market Net Sales Share, By Geography, 2023 (%)